Innovide, Operator of Dentlink, Secures 12 Billion Won in Series B Funding

Innovide, which operates the global next-generation dental laboratory service Dentlink, is accelerating its business expansion after securing an investment worth approximately 12 billion won.

On the 23rd, Innovide announced that it has raised 12 billion won in Series B funding. This funding round was led by SBVA, with IBK Industrial Bank of Korea joining as a new investor. Existing investors, including Wonik Investment Partners, Translink Investment, and Murex Partners, also participated with follow-on investments.

Dentlink is a next-generation dental laboratory service that standardizes the process of manufacturing dental prosthetics and addresses the issue of prosthetic remakes based on digital dentistry technology. Because dental prosthetics must be custom-made for each patient, quality control and standardization of manufacturing processes have traditionally been challenging. Dentlink has digitized the entire process—from data acquisition and production to quality control (QC) and logistics—reducing the prosthetic remake rate from around 10% to the 1% range.

Dentlink supplies high-quality prosthetics to dental clinics in six countries: the United States, Australia, Canada, New Zealand, Singapore, and the United Kingdom. In particular, through a strategic partnership with Straumann, the world's leading implant manufacturer, Dentlink plans to expand its customized service by providing its digital prosthetic manufacturing services to Straumann’s customers.

With the proceeds from this investment, Innovide will accelerate its business expansion in the U.S. and Australian markets and plans to establish an automated dental prosthetics manufacturing center in Korea, which will include a robot-linked production line. Through this, the company aims to advance Korea’s dental laboratory infrastructure and secure stable production capabilities to meet global demand. Additionally, Innovide will actively seek to recruit top talent in core research and development (R&D) for the development of AI-based dental prosthetic services and products.

Jinhyuk Kook, CEO of Innovide, stated, "We will use this funding as a stepping stone to further advance our technology and manufacturing infrastructure, thereby revolutionizing the global dental laboratory market."

This content was produced with the assistance of AI translation services.